Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Kudo K, Kojima S, Tabuchi K, Yabe H, Tawa A, Imaizumi M, Hanada R, Hamamoto K, Kobayashi R, Morimoto A, Nakayama H, Tsuchida M, Horibe K, Kigasawa H, Tsukimoto I; Japanese Childhood AML Cooperative Study Group. Kudo K, et al. J Clin Oncol. 2007 Dec 1;25(34):5442-7. doi: 10.1200/JCO.2007.12.3687. J Clin Oncol. 2007. PMID: 18048827 Clinical Trial.
Plasmacytoid dendritic cell leukemia in children.
Hama A, Kudo K, Itzel BV, Muramatsu H, Nishio N, Yoshida N, Takahashi Y, Yagasaki H, Ito M, Kojima S. Hama A, et al. Among authors: kudo k. J Pediatr Hematol Oncol. 2009 May;31(5):339-43. doi: 10.1097/MPH.0b013e31819b7215. J Pediatr Hematol Oncol. 2009. PMID: 19415013
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, Yabe H, Nakayama H, Kudo K, Kobayashi R, Hamamoto K, Imaizumi M, Morimoto A, Tsuchiya S, Hanada R. Tsukimoto I, et al. Among authors: kudo k. J Clin Oncol. 2009 Aug 20;27(24):4007-13. doi: 10.1200/JCO.2008.18.7948. Epub 2009 Jul 20. J Clin Oncol. 2009. PMID: 19620491
Forty-two-day-old boy with acute idiopathic thrombocytopenic purpura.
Kato K, Kobayashi C, Katayama Y, Moriyama N, Shiono J, Kudo K, Koike K, Aoki K, Fujisawa K, Okada M, Matsumoto M, Fujimura Y, Tsuchida M. Kato K, et al. Among authors: kudo k. Pediatr Int. 2010 Jun;52(3):485-7. doi: 10.1111/j.1442-200X.2010.03037.x. Pediatr Int. 2010. PMID: 20723123 No abstract available.
Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study.
Imaizumi M, Tawa A, Hanada R, Tsuchida M, Tabuchi K, Kigasawa H, Kobayashi R, Morimoto A, Nakayama H, Hamamoto K, Kudo K, Yabe H, Horibe K, Tsuchiya S, Tsukimoto I. Imaizumi M, et al. Among authors: kudo k. Br J Haematol. 2011 Jan;152(1):89-98. doi: 10.1111/j.1365-2141.2010.08332.x. Br J Haematol. 2011. PMID: 20735397 Free article. Clinical Trial.
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimens for pediatric acute leukemia.
Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J, Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K. Kato M, et al. Among authors: kudo k. Biol Blood Marrow Transplant. 2013 Dec;19(12):1690-4. doi: 10.1016/j.bbmt.2013.09.012. Epub 2013 Sep 23. Biol Blood Marrow Transplant. 2013. PMID: 24071595 Free article.
Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.
Muramatsu H, Sakaguchi H, Taga T, Tabuchi K, Adachi S, Inoue M, Kitoh T, Suminoe A, Yabe H, Azuma E, Shioda Y, Ogawa A, Kinoshita A, Kigasawa H, Osugi Y, Koike K, Kawa K, Kato K, Atsuta Y, Kudo K. Muramatsu H, et al. Among authors: kudo k. Pediatr Blood Cancer. 2014 May;61(5):925-7. doi: 10.1002/pbc.24883. Epub 2013 Dec 2. Pediatr Blood Cancer. 2014. PMID: 24302531
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol.
Nakayama H, Tabuchi K, Tawa A, Tsukimoto I, Tsuchida M, Morimoto A, Yabe H, Horibe K, Hanada R, Imaizumi M, Hayashi Y, Hamamoto K, Kobayashi R, Kudo K, Shimada A, Miyamura T, Moritake H, Tomizawa D, Taga T, Adachi S. Nakayama H, et al. Among authors: kudo k. Int J Hematol. 2014 Aug;100(2):171-9. doi: 10.1007/s12185-014-1616-9. Epub 2014 Jun 25. Int J Hematol. 2014. PMID: 24961644
1,759 results